Diversify Your Clinical Trials and Stay FDA Compliant with REDPlanUP
REDPlanUP is a unique state-of-the-art solution that provides insights into the race and ethnicity diversity of patients treated by investigators. It helps pharmaceutical companies identify investigators treating diverse patient populations as directed by FDA for clinical trials.
Our product ensures quicker enrollment of patients in clinical trials for pharma and life sciences organizations through appropriate representation of all races and ethnicities in the trials.
- Our Value Proposition
Inclusion of Un- and Under-Represented Participants
REDPlanUP ensures that clinical trials represent the full diversity of the US population, allowing for safer and more effective medications for everyone.
Savings for Pharma Sponsors
By partnering with investigators best suited for their specific trials, REDPlanUp helps pharmaceutical sponsors optimize costs and resources.
Faster Medications to Market
REDPlanUP fast tracks drug development and market launch with quicker enrollment of patients with diverse racial backgrounds.
- How Does it Work
This is the heading
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Robust Race Diversity Index
Get an in-depth analysis of payer behaviors and reimbursement policies to understand the potential market access and pricing challenges for your products.
Demographic and Investigator Information
Develop effective market access strategies driven by payer preferences, formulary decisions, and coverage requirements to tailor your value proposition and navigate reimbursement hurdles.
Historical and Current Trial Involvement
Optimize pricing and reimbursement strategies based on payer priorities and trends. Set competitive prices, negotiate favorable reimbursement terms, and maximize market penetration while maintaining profitability.
